Piper Sandler Downgrades Zimmer Biomet Holdings to Neutral, Lowers Price Target to $115

Benzinga · 07/01 09:49
Piper Sandler analyst Matthew O'Brien downgrades Zimmer Biomet Holdings (NYSE:ZBH) from Overweight to Neutral and lowers the price target from $140 to $115.